150
Participants
Start Date
November 3, 2020
Primary Completion Date
December 16, 2025
Study Completion Date
December 16, 2025
Biopsy Procedure
Undergo tumor biopsy
Biospecimen Collection
Undergo blood collection
Bone Marrow Biopsy
Undergo bone marrow biopsy
Bone Scan
Undergo bone scan
Computed Tomography
Undergo CT or PET/CT
Magnetic Resonance Imaging
Undergo MRI
Olaparib
Given PO
Positron Emission Tomography
Undergo PET/CT
ACTIVE_NOT_RECRUITING
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
RECRUITING
NYP/Weill Cornell Medical Center, New York
RECRUITING
NCI - Center for Cancer Research, Bethesda
ACTIVE_NOT_RECRUITING
University of Kentucky/Markey Cancer Center, Lexington
ACTIVE_NOT_RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
RECRUITING
UCHealth University of Colorado Hospital, Aurora
RECRUITING
Huntsman Cancer Institute/University of Utah, Salt Lake City
ACTIVE_NOT_RECRUITING
Los Angeles General Medical Center, Los Angeles
ACTIVE_NOT_RECRUITING
USC / Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
UC San Diego Health System - Encinitas, Encinitas
RECRUITING
UC San Diego Moores Cancer Center, La Jolla
RECRUITING
UC San Diego Medical Center - Hillcrest, San Diego
RECRUITING
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
ACTIVE_NOT_RECRUITING
USC Norris Oncology/Hematology-Newport Beach, Newport Beach
RECRUITING
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
SUSPENDED
University of California Davis Comprehensive Cancer Center, Sacramento
RECRUITING
University of Texas Medical Branch, Galveston
National Cancer Institute (NCI)
NIH